The British Medical Association has announced a fresh round of strikes in England in the long-running pay dispute.

Resident doctors, the new name for junior doctors, will stage a five-day walkout from 17 December.

This will be the 14th strike by the doctors’ union since March 2023 and is expected to cause significant disruption, particularly in hospitals.

Resident doctors represent nearly half the medical workforce and range from doctors fresh out of university through to those with up to a decade of experience.

They will walk out of both emergency and routine care, with senior doctors brought in to provide cover.

It follows a five-day strike held last month and that came after talks broke down between the government and union.

The government had offered doctors a deal which involved creating more training posts, improving working conditions and helping them with out-of-pocket expenses such as exam fees.

But the BMA turned that down, saying any deal needed to involve an increase in pay.

Health Secretary Wes Streeting has maintained he would not negotiate on pay after resident doctors had received pay rises totalling nearly 30% in the past three years.

But the union argues that, despite the pay rises, resident doctors’ pay is still a fifth lower than it was in 2008, once inflation is taken into account.

Dr Jack Fletcher, chairman of the BMA’s resident doctors committee, said as the government had failed to come forward with a credible plan the union had been left with no choice.

But he added: “These [strikes] do not need to go ahead. Gradually raising pay over a few years and some common-sense fixes to the job security of our doctors are well within the reach of this government.”

The BMA’s mandate for strike action ends in early January, but it has announced it will be holding another ballot of members.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

FDA Blocked Melanoma Drug as Confusion Reigned Under Makary

The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had

Research on clozapine safety: Big-data evidence on rare blood cancer cases

An inter-departmental research team at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has conducted the world’s first analytic real-world cohort study on the association of

Preventive care may no longer be free in 2026 because of HIV stigma − unless the Trump administration successfully defends the ACA

Many Americans were relieved when the Supreme Court left the Affordable Care Act in place following the law’s third major legal challenge in June 2021. This decision permitted widely supported